Not Yet RecruitingNCT06799689
Official study titleEFFECT OF ESMADEM EDUCATION MODEL ON RELIGIOUS COPING, TOLERANCE AND DEPRESSION OF RISKY PREGNANTS
This study isn't recruiting yet.
Location not clearly listedDepressionBehavioural studyAges 18–35
- Countries
- Sponsor
- Burdur Mehmet Akif Ersoy University
Not Yet RecruitingNCT06813313
Official study titleRandomized Controlled Trial of Two Accelerated Transcranial Magnetic Stimulation Methods in the Treatment of Resistant Depression: Intermittent Theta Burst Stimulation With an 8-Coil Versus H1-Coil
This study isn't recruiting yet.
Location not clearly listedDepressionDevice studyAges 18+
- Countries
- Sponsor
- Dominique JANUEL
Not Yet RecruitingNCT07279025
Official study titleSymptom Evaluation and Quantification for Unified Outcomes and Individualized Assessment
This study isn't recruiting yet.
In HoustonDepression, AnxietyObservational studyAges 18–65
- Countries
- United States
- Sponsor
- Deliberate Solutions Inc.
Not Yet RecruitingNCT07637097
Official study titleReducing Depression in Family Caregivers of Persons Living With Lewy Body Dementia Through Tailored Asynchronous Online Intervention.
This study isn't recruiting yet.
In SeattleDepressionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of Washington
CompletedNCT06309277
What is this study about?This study evaluated the safety of GM-1020 for people with depression.
This study has finished and is no longer accepting participants.
In ManchesterDepressionMedication studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- Gilgamesh Pharmaceuticals
CompletedNCT00130676
What is this study about?Researchers compared Mifepristone and placebo, tracking side effects to assess safety in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Pico RiveraDepression, SchizophreniaMedication studyAges 18–75
- Countries
- United States
- Sponsor
- Corcept Therapeutics
CompletedNCT00128479
What is this study about?Researchers compared mifepristone, mifepristone 600 mg, mifepristone 1200 mg and placebo, tracking side effects to assess safety in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockDepression, SchizophreniaMedication studyAges 18–75
- Countries
- United States
- Sponsor
- Corcept Therapeutics
Enrolling By InvitationNCT04982757
This study is by invitation only.
In New YorkDepression, OCDDevice studyAges 18–75
- Countries
- United States
- Sponsor
- Weill Medical College of Cornell University
CompletedNCT00128505
What is this study about?Researchers studied Mifepristone to find out how it affected psychotic symptoms in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including SofiaDepression, SchizophreniaMedication studyAges 18–75
- Countries
- Bulgaria, Croatia, Romania, + 1 other
- Sponsor
- Corcept Therapeutics
Enrolling By InvitationNCT06273982
Official study titleBehavioral Telehealth in Low-resource Primary Care Settings for Anxiety and Depression in Youth: A Randomized Effectiveness-implementation Study
This study is by invitation only.
In PortlandDepression, AnxietyBehavioural studyAges 8–16
- Countries
- United States
- Sponsor
- San Diego State University